Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Alper H.YUKSEL who wrote (25752)	9/24/1998 1:40:00 PM
From: RXGOLF	Respond to of 32384

OFF Topic: For some of us, I am sorry to say that ammunition was not the problem. Not enough faith or guts was my demise for this run :- (! Happy investing, Greg

To: Alper H.YUKSEL who wrote (25752)	9/24/1998 4:41:00 PM
From: Michael Massimilla	Read Replies (1) \| Respond to of 32384

Good thought, but in practice it's very difficult to judge the bottom. I originally bought some LGNDW at $6, bought some more at $7 on the way up to $10 (feeling pretty good there), sold a little when it dropped to $9, and then watched as it started dropping more. On the way down I bought a little more at $7, some more at $5 1/2 (where the chart showed a lot of resistance), and some more at $4 1/2 (surely a bottom there). I never figured it would drop to $1 1/2. At that point I already had all the LGNDW I was willing to buy and was contemplating the June 2000 expiration which would make LGNDW worthless at the prevailing stock price. What I learned is that biotechs are very risky and their stocks highly volatile to begin with, and when you play with warrants on them besides, you are in for a roller-coaster ride that might not have a pleasant outcome. A more sensible approach is to take a modest position in the stock. Given the risky nature of the biotech business, it is best to take a cautious approach to investing in it.

To: Alper H.YUKSEL who wrote (25752)	9/24/1998 8:45:00 PM
From: Henry Niman	Respond to of 32384

The Bear Stearns update on SBH includes the following on Avandia: *** Avandia remains on track for a mid-December NDA filing for monotherapy and Phase III combination studies are being conducted with sulfonylureas, metformin and insulin use. Targretin synergizes with Avandia for treating type II diabetes as well as various cancers.

To: Alper H.YUKSEL who wrote (25752)	9/24/1998 8:50:00 PM
From: Henry Niman	Read Replies (2) \| Respond to of 32384

Actually, LGND is near the top of the NASDAQ list of percentage gainers for stocks that have risen for the past 5 days: NASDAQ Stocks With Price Up The Past 5 Days At 4:30 PM - PART 1 OF 2 ALEXANDRIA, VA, September 24, 1998 (COMTEX) -- Today's stocks on the Nasdaq Stock Market that have advanced in price in each of the past 5 days. 5-Day Last Change Volume %Gain Marquette Medical Sys 43 3/8 +1/8 320,600 81% ArQule Inc 7 +5/8 100,300 62% TMTV 2 7/16 +3/16 12,300 56% Com21 Inc 18 +1/2 116,200 53% Excite Inc 39 1/8 +1 3/8 21,976,800 49% Ligand Pharmaceuticals 10 1/2 +3/8 589,100 49% Datastream Systems 15 15/16 +13/16 256,400 47% CommNet Cellular Inc 12 1/8 +7/16 15,500 47% IDT Corp 27 1/8 +2 15/16 923,200 45% Health Mgmt Systems 8 1/2 +7/8 183,500 45% Pinnacle Systems Inc 27 1/8 +3/8 254,100 39% Pixar 47 1/2 +1 5/8 366,000 38% Lycos Inc 33 5/8 +3/8 8,302,900 38% Electro Rent Corp 14 3/4 +3/8 45,700 34% Balance Bar Co 13 1/4 +1 73,700 33% Jones Pharma Inc 30 1/4 +2 5/8 960,500 32% Integrated Silicon Solution 3 7/8 +1/32 65,400 32% Intermedia Comm 31 3/4 +1/4 925,400 30% York Research Corp 4 3/8 +1/4 51,900 30% Neose Technologies 11 1/4 +1/2 13,700 29% Village Super Market 23 1/4 +1/2 5,600 29% DM Management Co 10 1/8 +1/8 61,900 29% Astec Industries Inc 40 7/8 +7/8 41,700 28% Xybernaut Corp 5 15/32 +9/32 941,300 27% Integrated Device Tech 5 15/32 +5/32 830,700 25% Metro Info Services 37 3/8 +1 1/4 74,400 23% Peregrine Systems 41 +1 3/8 731,700 22% NeXstar Pharmaceuticals 10 1/8 +1/4 174,400 21%